OBIO Investment Summit 2021 | Ontario Bioscience Innovation Organization (OBIO) | 9 February 2021 | Online

Join leading global investors, scientific experts, and Canada's most promising health science companies at the 2021 OBIO Investment Summit, taking place online February 9 to 10, 2021.

Building on the success of the 2020 OBIO Investment Summit, which featured hundreds of investor-company introductions, OBIO invites you to discover the best of what Canada has to offer.

The Summit will drive investment in Canada by attracting capital, allowing companies and innovators to grow here, scale here and develop their businesses here. The Summit will feature a mixture of company pitch sessions, keynote presentations and one-on-one meeting opportunities.

2021 Speakers

Michael Houghton
Director of the Li Ka Shing Applied Virology Institute in the University of Alberta and is the Li Ka Shing Professor within the Department of Medical Microbiology & Immunology in the Faculty of Medicine and Dentistry

Mira Johri, PhD M
Professor in the Department of Health Management, Evaluation and Policy at the School of Public Health, University of Montreal, and Principal Scientist at the University of Montreal Hospital Research Centre (CRCHUM).

John Bell
Senior Scientist at the Ottawa Hospital Research Institute and Professor of Medicine at the University of Ottawa

Jung-Kay Chiu, B.SC, LLB
national practice head of the Canadian intellectual property practice at Norton Rose Fulbright

Dr. Maura Campbell
Vice President, Intellectual Property and Contracts, Turnstone Biologics

Michael Rudnicki
Senior Scientist and the Director of the Regenerative Medicine Program and the Sprott Centre for Stem Cell Research at the Ottawa Hospital Research Institute

2021 Sponsors and Partners

SPONSORS:
• Lumira Venture
• Norton Rose Fulbright
• Innovative Medicines Canada
• Prolucid

PARTNERS:
• Biomedical Zone
• Bam
• Communitech
• CQDM
• CQIB
• Health City
• Johnson & Johnson Innovation
• McGill
• Montreal Invivo
• Quark Venture